In September 2023, Blau Farmacêutica, a company that produces highly complex and essential hospital medicines aimed at human health, approved the 6th Issuance of simple, non-convertible, unsecured debentures, in a single series, in the total amount of BRL 350 million. The lead coordinator of the offering was Banco Itaú BBA S.A. and the trustee was Oliveira Trust Distribuidora de Títulos e Valores Mobiliários S.A.